Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy

Tero Puolakkainen, Hongqian Ma, Heikki Kainulainen, Arja Pasternack, Timo Rantalainen, Olli Ritvos, Kristiina Heikinheimo, Juha Hulmi, Riku Kiviranta

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number20
JournalBMC Musculoskeletal Disorders
Volume18
Number of pages11
ISSN1471-2474
DOIs
Publication statusPublished - 19 Jan 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • Bone mu CT
  • Bone-muscle interactions
  • TGF-beta s
  • Animal models
  • Exercise
  • MUSCLE PROTEIN-SYNTHESIS
  • MDX MICE
  • OXIDATIVE CAPACITY
  • MYOSTATIN
  • EXERCISE
  • DENSITY
  • METAANALYSIS
  • DEFICIENCY
  • PREVENTS
  • BLOCKING
  • 3126 Surgery, anesthesiology, intensive care, radiology
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this